Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Metachronous colorectal malignancies

M V Agrez, R Ready, D Ilstrup

Diseases of the Colon and Rectum

|September 1, 1982

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to Zhuo et al. (2013): experience of a specialist centre in the management of anastomotic sinus following leaks after low rectal or ileal pouch-anal anastomosis with diverting stoma.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2014

Same author

Diagnosis and management of recurrent colorectal cancer.

Acta chirurgica Iugoslavica·2008

Same author

The prognostic impact of the time interval to recurrence for the mortality in recurrent colorectal cancer.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2006

Same author

A survey of perceptions and attitudes among European surgeons towards the clinical impact and management of postoperative ileus.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2005

Same author

Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells.

British journal of cancer·2002

Same author

Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade.

Carcinogenesis·2002

Metachronous colorectal cancer patients often develop a second tumor within 5.5 years. Lifelong colon evaluations are crucial after initial colorectal cancer surgery to detect subsequent malignancies.

Area of Science:

Oncology
Gastroenterology
Surgical Oncology

Background:

Metachronous colorectal malignancies represent a significant challenge in patient management.
Understanding the temporal patterns and risk factors for second and third colorectal cancers is vital.

Purpose of the Study:

To analyze the incidence and timing of metachronous colorectal malignancies.
To identify factors influencing the interval between colorectal cancer resections.
To evaluate survival outcomes and recurrence patterns in patients with multiple colorectal tumors.

Main Methods:

Retrospective review of 62 patients with metachronous colorectal malignancies treated at Mayo Clinic.
Analysis of patient demographics, tumor characteristics, treatment timelines, and survival data.

Related Experiment Videos

Correlation analysis between age at first surgery and time to second resection.

Main Results:

50% of patients developed a second colorectal carcinoma within 5.5 years; the interval ranged from 1 to 23 years.
40% of patients had co-existing adenomas.
A negative correlation existed between age at first surgery and the interval to the second resection.
The 5-year survival probability after resection of metachronous lesions was 59%.
11% of patients developed a third metachronous lesion.

Conclusions:

Metachronous colorectal malignancies necessitate aggressive surgical management with curative intent.
Lifelong, periodic, total colonic surveillance is essential following the resection of a first colorectal carcinoma.
Early detection and management of subsequent tumors significantly impact patient survival.